Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-06-07 Sale |
2021-06-09 4:28 pm |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $142.65 | $1,426,513 | 52,868 (Direct) |
View |
2021-05-26 Sale |
2021-05-27 6:15 pm |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $124.55 | $1,245,470 | 47,414 (Direct) |
View |
2020-11-12 Sale |
2020-11-13 3:44 pm |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
3,500 | $176.02 | $616,070 | 21,580 (Direct) |
View |
2020-06-01 Sale |
2020-06-01 5:27 pm |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
2,000 | $143.97 | $287,940 | 23,580 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-06-07 Conversion |
2021-06-09 4:28 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $0 | 52,868 (Direct) |
View |
2021-06-07 Exercise |
2021-06-09 4:28 pm |
N/A 2026-12-07 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $0 | 52,868 (Direct) |
View |
2021-06-07 Exercise |
2021-06-09 4:28 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $22.57 | 52,868 (Direct) |
View |
2021-05-26 Exercise |
2021-05-27 6:15 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
2,934 | $11 | 47,414 (Direct) |
View |
2021-05-26 Conversion |
2021-05-27 6:15 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $0 | 47,414 (Direct) |
View |
2021-05-26 Exercise |
2021-05-27 6:15 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $0 | 47,414 (Direct) |
View |
2021-05-26 Exercise |
2021-05-27 6:15 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
7,066 | $22.57 | 47,414 (Direct) |
View |
2021-01-04 Option Award |
2021-01-06 4:13 pm |
N/A 2031-01-04 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
8,000 | $0 | 8,000 (Direct) |
View |
2020-11-18 Gift |
2020-11-19 4:08 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
600 | $0 | 14,546 (Direct) |
View |
2020-11-12 Exercise |
2020-11-13 3:44 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
3,500 | $11 | 21,580 (Direct) |
View |
2020-11-12 Conversion |
2020-11-13 3:44 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
3,500 | $0 | 21,580 (Direct) |
View |
2020-11-12 Exercise |
2020-11-13 3:44 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
3,500 | $0 | 21,580 (Direct) |
View |
2020-06-01 Exercise |
2020-06-01 5:27 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
2,000 | $11 | 23,580 (Direct) |
View |
2020-06-01 Conversion |
2020-06-01 5:27 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
2,000 | $0 | 23,580 (Direct) |
View |
2020-06-01 Exercise |
2020-06-01 5:27 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
2,000 | $0 | 23,580 (Direct) |
View |